Evidence map›Paper›PMID 35289010›Full record

ArticleAddiction (Abingdon, England)2022

The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings.

Valentina Lorenzetti, Chandni Hindocha, Kat Petrilli, Paul Griffiths, Jamie Brown, Álvaro Castillo-Carniglia, Jonathan P Caulkins, Amir Englund, Mahmoud A ElSohly, Suzanne H Gage and 15 more

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Addiction (Abingdon, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Valentina LorenzettiNeuroscience of Addiction and Mental Health Program, the Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Faculty of Health, Australian Catholic University, Melbourne, Australia.ORCID 0000-0002-5917-7068
Chandni HindochaClinical Psychopharmacology Unit, University College London, London, UK.
Kat PetrilliAddiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, Somerset, UK.
Paul GriffithsEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal.
Jamie BrownDepartment of Behavioural Science and Health, Institute of Epidemiology & Health Care, University College London, London, UK.
Álvaro Castillo-CarnigliaSociety and Health Research Center, Universidad Mayor, Millennium Nucleus for the Evaluation and Analysis of Drug Policies (nDP), and Millennium Nucleus on Sociomedicine (SocioMed), Chile.
Jonathan P CaulkinsCarnegie Mellon University Heinz College, Pittsburgh, PA, USA.
Amir EnglundAddictions Department, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK.
Mahmoud A ElSohlyNational Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, Mississippi, USA.
Suzanne H GageDepartment of Psychology, Institute of Population Health, University of Liverpool, Liverpool, UK.
Teodora GroshkovaEuropean Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal.
Antoni GualAddictions Research Group. Psychiatry Department, Neurosciences Institute. Hospital Clínic. IDIBAPS. RTA. Barcelona, Spain.
David HammondSchool of Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
Will LawnClinical Psychopharmacology Unit, University College London, London, UK.
Hugo López-PelayoAddictions Research Group. Psychiatry Department, Neurosciences Institute. Hospital Clínic. IDIBAPS. RTA. Barcelona, Spain.
Jakob MantheyCenter for Interdisciplinary Addiction Research, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Claire MokryszClinical Psychopharmacology Unit, University College London, London, UK.
Rosalie Liccardo PaculaUSC Sol Price School of Public Policy, USC Leonard D. Schaeffer Center for Health Policy & Economics, California, Los Angeles, USA.
Margriet van LaarTrimbos Institute, Utrecht, The Netherlands.
Ryan VandreyDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Elle WadsworthSchool of Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
Adam WinstockDepartment of Behavioural Science and Health, Institute of Epidemiology & Health Care, University College London, London, UK.
Wayne HallQueensland Alliance for Environmental Health Sciences, The University of Queensland, Australia.
H Valerie CurranClinical Psychopharmacology Unit, University College London, London, UK.
Tom P FreemanAddiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, Somerset, UK.

Funding

Cancer Research UK 22962
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabisMedical MarijuanaCross-Cultural ComparisonHumansMedical MarijuanaAssessmentcannabisdoseiCannToolkitinternational cannabis toolkitmeasurementstandardization

Identifiers

PMID35289010
PMCPMC9314823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.